Insider Kevin K. Engel Sells Shares under Rule 144

Kevin K. Engel reported planned sales of company common stock under Rule 144.

Rhea-AI Filing Summary

Kevin K. Engel reported planned sales of company common stock under Rule 144. The filing lists dispositions of 5,316 shares on 02/17/2026 for $244,719.40 and 11,000 shares on 12/12/2025 for $508,292.40.

The notice also records recent issuer awards: 786 restricted shares on 02/16/2026, 9,914 restricted shares on 02/20/2026, and 1,800 performance shares on 02/18/2026.

Insights

Insider Transactions Analyst

Insider disclosed Rule 144 dispositions totaling specified share counts and proceeds.

The filing lists two reported dispositions: 5,316 shares sold on 02/17/2026 for $244,719.40 and 11,000 shares sold on 12/12/2025 for $508,292.40. These are reportable Section 144 transactions rather than broader corporate actions.

Timing and cash‑flow treatment are explicit for each disposition; subsequent filings may show additional trades or employer stock awards. No material change to company operations is indicated in this excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AMKR insider Kevin K. Engel report in the Form 144?

He reported two dispositions: 5,316 shares on 02/17/2026 and 11,000 shares on 12/12/2025. The filing shows proceeds of $244,719.40 and $508,292.40, respectively, and lists recent issuer awards dated in February 2026.

How much cash did Kevin K. Engel receive from the reported sales?

The filing shows proceeds of $244,719.40 and $508,292.40 from the two sales. Those amounts correspond to 5,316 shares sold on 02/17/2026 and 11,000 shares sold on 12/12/2025, as disclosed in the Form 144 excerpt.

Does the filing show any recent stock awards for AMKR executives?

Yes. The excerpt records issuer grants in February 2026: 786 restricted shares, 9,914 restricted shares, and 1,800 performance shares. Each award is dated: 02/16/2026, 02/20/2026, and 02/18/2026, respectively.

Is the Form 144 sale information sufficient to determine ongoing selling plans?

The filing discloses specific past dispositions and award dates but does not state an ongoing plan. It lists discrete sales on 12/12/2025 and 02/17/2026; no standing Rule 10b5-1 plan or future sale schedule is shown in the excerpt.

Which securities exchange is referenced in the filing excerpt?

The excerpt references NASDAQ for the common stock listing. The filing header includes exchange information alongside issuer and share details, confirming the listed market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965254
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMKOR TECHNOLOGY, INC.
SEC File Number	000-29472
Address of Issuer	2045 East Innovation Circle Tempe ARIZONA 85284
Phone	(480) 821-5000
Name of Person for Whose Account the Securities are To Be Sold	KEVIN K ENGEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12500	609318.75	247309063	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2026	Restricted Stock	Issuer			786	02/16/2026	Not Applicable
Common	02/20/2026	Restricted Stock	Issuer			9914	02/20/2026	Not Applicable
Common	02/18/2026	Performance Shares	Issuer			1800	02/18/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KEVIN K ENGEL 2045 East Innovation Circle Tempe AZ 85284	Common	02/17/2026	5316	244719.40
KEVIN K ENGEL 2045 East Innovation Circle Tempe AZ 85284	Common	12/12/2025	11000	508292.40

144: Remarks and Signature

Remarks
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kevin Engel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)